Henry Schein Inc
NASDAQ:HSIC

Watchlist Manager
Henry Schein Inc Logo
Henry Schein Inc
NASDAQ:HSIC
Watchlist
Price: 73.79 USD 0.61% Market Closed
Market Cap: 8.7B USD

Henry Schein Inc
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Henry Schein Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Henry Schein Inc
NASDAQ:HSIC
Cash from Operating Activities
$535m
CAGR 3-Years
-5%
CAGR 5-Years
0%
CAGR 10-Years
0%
Cardinal Health Inc
NYSE:CAH
Cash from Operating Activities
$5B
CAGR 3-Years
9%
CAGR 5-Years
12%
CAGR 10-Years
8%
Adapthealth Corp
NASDAQ:AHCO
Cash from Operating Activities
$569m
CAGR 3-Years
15%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Patterson Companies Inc
NASDAQ:PDCO
Cash from Operating Activities
-$804.6m
CAGR 3-Years
6%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Mckesson Corp
NYSE:MCK
Cash from Operating Activities
$6.9B
CAGR 3-Years
16%
CAGR 5-Years
9%
CAGR 10-Years
5%
Cencora Inc
NYSE:COR
Cash from Operating Activities
$3.9B
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
0%
No Stocks Found

Henry Schein Inc
Glance View

In the evolving landscape of healthcare distribution, Henry Schein Inc. has carved out a robust niche, establishing itself as a pivotal player in delivering essential products and services. Founded in 1932, the company initially responded to the growing need for medical supplies with a simple commitment to customer service and innovation. Today, the company profiles as the world’s largest provider of healthcare products and services to office-based dental and medical practitioners, alongside its veterinary arm. It services a global footprint, channeling its efforts into dental, medical, and animal health sectors. The company's sprawling network deploys a vast array of products—from consumables to equipment—to a multitude of healthcare professionals, accentuating its integral role in the clinical toolkit. Henry Schein's revenue engine thrives on a meticulously crafted business model that combines the breadth of a comprehensive catalog with targeted value-added services. Its diverse product offerings span dental implants, vaccines, pharmaceuticals, and surgical supplies, delivered through direct sales and sophisticated logistical frameworks. Moreover, Henry Schein supplements its product lines with a suite of services, including practice management solutions and e-commerce platforms, that streamline operations for practitioners and enhance client loyalty. Strategic partnerships and acquisitions show the company's commitment to innovation, driving efficiencies and expanding its reach. This continuous adaptation keeps Henry Schein at the forefront of healthcare trends, ensuring steady streams of income flowing from both longstanding relationships and new market opportunities.

HSIC Intrinsic Value
HIDDEN
Show

See Also

What is Henry Schein Inc's Cash from Operating Activities?
Cash from Operating Activities
535m USD

Based on the financial report for Sep 27, 2025, Henry Schein Inc's Cash from Operating Activities amounts to 535m USD.

What is Henry Schein Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
0%

Over the last year, the Cash from Operating Activities growth was -13%. The average annual Cash from Operating Activities growth rates for Henry Schein Inc have been -5% over the past three years .

Back to Top